Cutaneous B-cell lymphoma--a clinical, pathological and immunohistochemical study

Area of Science:

• Oncology
• Dermatology
• Hematopathology

Background:

• Cutaneous B-cell lymphoma (CBCL) is a heterogeneous group of non-Hodgkin lymphomas.
• Understanding the diverse clinical and pathological features of CBCL is crucial for accurate diagnosis and prognosis.

Purpose of the Study:

• To investigate the clinical, pathological, and immunohistochemical characteristics of eleven CBCL cases.
• To identify potential prognostic indicators within CBCL subtypes.

Main Methods:

• Analysis of clinical data from eleven CBCL patients, including age, sex, tumor presentation, and disease stage.
• Histopathological examination of biopsy specimens, focusing on tumor location within the skin.
• Immunohistochemical analysis using CD20, CD22, and CD10 markers to characterize B-cell populations.

Main Results:

• CBCL cases presented with solitary or multiple tumors, with stages ranging from I to IV.
• Neoplastic cells primarily affected the reticular dermis and subcutis; epidermotropism was absent.
• Immunohistochemistry revealed CD20/CD22 positivity in most cases, with CD10 positivity in two diffuse large cell/pre-B-cell lymphomas.

Conclusions:

• Two distinct prognostic groups of CBCL were identified: a benign, low-grade type with solitary tumors and an intermediate-grade pathology, and a high-grade type with multiple tumors and a poor prognosis.
• Prognosis in CBCL appears correlated with tumor number, B-cell differentiation markers (pre-B-cell vs. mature B-cell), and histopathological grade.